Clinical Trials Browser

Phase 2 × HER2 peptide (369-377) × Clear all

NCT02297698 2023-12-12

HER3+

Phase 2 Completed

100 enrolled 11 charts

Breast Neoplasms

NCT02636582 2023-12-05

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

Phase 2 Completed

43 enrolled 10 charts

Carcinoma, Intraductal, Noninfiltrating

NCT01570036 2020-12-02

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Phase 2 Completed

275 enrolled 23 charts

Breast Neoplasms, Breast Neoplasms, Male